Amicus Therapeutics, Inc. 2025-2026 Proxy Voting Records

Description as filed by funds: To adopt the Agreement and Plan of Merger (as it may be amended from time to time, the "Merger Agreement"), dated December 19, 2025, by and among Amicus Therapeutics, Inc., a Delaware corporation ("Amicus"), BioMarin Pharmaceutical Inc., a Delaware corporation ("BioMarin"), and Lynx Merger Sub 1, Inc., a Delaware corporation and wholly owned subsidiary of BioMarin ("Merger Sub"), pursuant to which Merger Sub will merge with and into Amicus (the "Merger"), and Amicus will become a direct or indirect wholly owned subsidiary of BioMarin.

Amicus Therapeutics, Inc.’s own tally for this item (“1. The Merger Proposal To adopt the Agreement and Plan of Merger (as it may be amended from time to time, the " Merger Agreement "), dated December 19, 2025, by and among the Company, Parent, and Lynx Merger Sub 1, Inc.,”): 234,593,492 for, 119,194 against — passed, per its Form 8-K filed March 3, 2026 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “Proposal 1: The Merger Proposal To adopt the Agreement and Plan of Merger (as it may be amended from time to time, the " Merger Agreement "), dated December 19, 2025, by and among the Company, Parent, and Lynx Merger Sub 1, Inc., a Delaware corporation and wholly owned subsidiary of Parent (" Merge…”
Support: 99.9% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 72 asset managers below reported 83,589,026 for.

Showing the 25 largest of 72 asset managers. See all 72 in the interactive database.

The 2 asset managers below reported 294,749 for. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

Description as filed by funds: To approve the adjournment of the special meeting, if necessary or appropriate, to solicit additional proxies if there are not sufficient votes in favor of the adoption of the Merger Agreement at the time of the special meeting.

The 71 asset managers below reported 74,335,795 for, 9,228,379 against, 24,503 abstained. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

Showing the 25 largest of 71 asset managers. See all 71 in the interactive database.

The 2 asset managers below reported 294,749 for. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

Description as filed by funds: To approve, on a non-binding, advisory basis, the payment of certain compensation that may be paid or become payable to Amicus' named executive officers that is based on or otherwise relates to the Merger.

Amicus Therapeutics, Inc.’s own tally for this item (“2. The Compensation Proposal To approve, on a non-binding, advisory basis, the payment of certain compensation that may be paid or become payable to the Company's named executive officers that is based on or otherwise re”): 209,150,012 for, 24,282,220 against — passed, per its Form 8-K filed March 3, 2026 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “The following advisory votes were cast at the Special Meeting (in person or by proxy) and the Compensation Proposal was approved:”
Support: 90% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).

Fund voting reports, all 71 managers: 78,355,688 for, 5,208,486 against, 24,503 abstained. Showing the 25 largest; see all in the interactive database.

Institutional-manager reports, all 236 managers: 127,721,077 for, 21,448,035 against, 60,706 abstained. Showing the 25 largest; see all in the interactive database.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice). The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

Fund voting reports, all 2 managers: 294,749 against.

Institutional-manager reports, all 4 managers: 6,367,824 for, 600 against.